3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
12
Fallopian Tube Neoplasms
8
Sarcoma
3
Sarcoma, Ewing
2
Neoplasms
2
Neoplasm Metastasis
2
Multi-centric Castleman's Disease
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Rhabdomyosarcoma
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Peritoneal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Cancer Recurrent
1
Osteosarcoma
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphadenopathy
1
Liposarcoma
1
Leiomyosarcoma
1
Hodgkin Disease
1
Histiocytoma, Malignant Fibrous
1
HIV Infections
1
Gliosarcoma
1
Glioblastoma
1
Interventions
Fluorouracil
11
Oxaliplatin
9
Leucovorin
7
Capecitabine
7
pembrolizumab
6
Specimen Handling
6
Nivolumab
6
trastuzumab deruxtecan
5
Magnetic Resonance Spectroscopy
5
fludarabine
4
Trastuzumab
4
Paclitaxel
4
Docetaxel
4
Cyclophosphamide
4
Cisplatin
4
Biopsy
4
zimberelimab
3
aldesleukin
3
Ramucirumab
3
ulixertinib
2
fludarabine phosphate
2
Irinotecan
2
Folfox protocol
2
zolbetuximab
1
zanidatamab
1
trifluridine tipiracil drug combination
1
trastuzumab biosimilar HLX02
1
trametinib
1
toripalimab
1
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
liposomal doxorubicin
×
30 days
×
Clear all
No trials found.